DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 44 filers reported holding DECIBEL THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $127,510 | -72.6% | 62,200 | -53.9% | 0.00% | – |
| Q3 2022 | $466,000 | -31.7% | 134,800 | -16.8% | 0.00% | – |
| Q2 2022 | $682,000 | +234.3% | 162,000 | +141.3% | 0.00% | – |
| Q1 2022 | $204,000 | -75.5% | 67,146 | -62.5% | 0.00% | – |
| Q4 2021 | $832,000 | +380.9% | 179,252 | +699.3% | 0.00% | – |
| Q3 2021 | $173,000 | +6.8% | 22,426 | +56.9% | 0.00% | – |
| Q1 2021 | $162,000 | – | 14,291 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,139,685 | $9,545,000 | 2.59% |
| Samsara BioCapital, LLC | 826,422 | $2,512,000 | 0.63% |
| Orbimed Advisors | 4,945,192 | $15,033,000 | 0.24% |
| Alphabet Inc. | 1,636,258 | $4,974,000 | 0.16% |
| HARVARD MANAGEMENT CO INC | 328,798 | $1,000,000 | 0.10% |
| Casdin Capital, LLC | 330,000 | $1,003,000 | 0.04% |
| Bronte Capital Management Pty Ltd. | 163,224 | $496,000 | 0.04% |
| MYDA Advisors LLC | 20,000 | $61,000 | 0.02% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 263,600 | $801,000 | 0.02% |
| ATLAS CAPITAL ADVISORS LLC | 41,025 | $124,716,000 | 0.02% |